Skip to main content
. 2026 Jun 8;26:1040. doi: 10.1186/s12877-026-07733-y

Table 1.

Selected baseline characteristics of participants according to tertiles of LTPA

Characteristic Overall (n = 416) T1 (≤ 0 min/wk) (n = 208) T2 (0–420 min/wk) (n = 83) T3 (> 420 min/wk) (n = 125) P value
Sociodemographic characteristics
Age, years 66.05 ± 4.80 66.12 ± 4.94 66.64 ± 4.54 65.54 ± 4.71 0.262
Sex, n (%)
 Male 167 (40.1) 79 (38.0) 34 (41.0) 54 (43.2) 0.633
 Female 249 (59.9) 129 (62.0) 49 (59.0) 71 (56.8)
Education level, n (%)
 Primary or below 95 (22.8) 48 (23.1) 24 (28.9) 23 (18.4) 0.109
 Middle/High school 234 (56.2) 125 (60.1) 40 (48.2) 69 (55.2)
 College or above 87 (20.9) 35 (16.8) 19 (22.9) 33 (26.4)
Marital status, n (%)
 Married/cohabiting 360 (86.5) 181 (87.0) 66 (79.5) 113 (90.4) 0.076
 Other 56 (13.5) 27 (13.0) 17 (20.5) 12 (9.6)
Living arrangement, n (%)
 Living alone 48 (11.5) 21 (10.1) 14 (16.9) 13 (10.4) 0.236
 Living with others 368 (88.5) 187 (89.9) 69 (83.1) 112 (89.6)
Residence, n (%)
 Urban 28 (6.7) 20 (9.6) 3 (3.6) 5 (4.0) 0.063
 Rural 388 (93.3) 188 (90.4) 80 (96.4) 120 (96.0)
Lifestyle and health-related characteristics
 Sleep duration, h/day 7.59 ± 1.14 7.59 ± 1.17 7.71 ± 1.21 7.51 ± 1.04 0.472
Current smoker, n (%)
 No 355 (85.3) 175 (84.1) 68 (81.9) 112 (89.6) 0.243
 Yes 61 (14.7) 33 (15.9) 15 (18.1) 13 (10.4)
Current drinker, n (%)
 No 318 (76.4) 158 (76.0) 65 (78.3) 95 (76.0) 0.904
 Yes 98 (23.6) 50 (24.0) 18 (21.7) 30 (24.0)
No. of chronic diseases 1.06 ± 1.23 1.05 ± 1.18 1.29 ± 1.52 0.91 ± 1.08 0.095
Fall risk score 0.75 ± 1.38 0.59 ± 1.26 1.05 ± 1.61 0.83 ± 1.38 0.029
Cognitive screening score 0.42 ± 0.92 0.39 ± 0.83 0.42 ± 0.91 0.47 ± 1.05 0.73
ST, min/day 160.12 ± 101.19 165.99 ± 106.97 152.89 ± 90.22 155.16 ± 98.31 0.492

Notes: Values are presented as mean ± standard deviation or n (%)

Fall risk score and cognitive screening score were questionnaire-derived summary scores and were analyzed as continuous variables; higher scores indicate higher fall risk and a greater number of cognitive-related problems, respectively

The cognitive screening score was used as a screening indicator rather than as a clinical diagnosis of cognitive impairment

P values were derived from one-way ANOVA or χ² test, as appropriate